TheCryptoChartWhisperer

IFRX 1D Continued

Alış
NASDAQ:IFRX   InflaRx N.V.
test
Just having some fun after a great ski trip to Breckenridge, Co for a couple of weeks. Let's get back into it.

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
İşlem kapandı: hedefe ulaştı
Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.